Cumberland County Schools address Mental Health Awareness Month fayobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fayobserver.com Daily Mail and Mail on Sunday newspapers.
St Luke s doctors discuss treatment for COVID-19 long haulers – Times News Online tnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tnonline.com Daily Mail and Mail on Sunday newspapers.
This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP) health
FDA OKs first new ADHD drug in over a decade for children Today 05:47 am JST Today | 06:48 am JST WASHINGTON
U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.
The Food and Drug Administration OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.